Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to
Yang Yang1, Yingjian He1, Zhaoqing Fan2
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.
NPJ Breast Cancer
|July 24, 2023
Abstract
No abstract available in PubMed .
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.3K
